Article
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers
2024-04-03
Abstract excerpt
<title>Abstract</title> <p>Interleukin-15 (IL15) promotes the survival of T lymphocytes and enhances the antitumor properties of CAR T cells in preclinical models of solid neoplasms in which CAR T cells have limited efficacy1-4. Glypican-3 (GPC3) is expressed in a group of solid cancers5-10, and here we report the first evaluation in humans of the effects of IL15 co-expression on GPC3-CAR T cells. Cohort 1 patien...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 145a06d5-49c6-5ce4-bf32-14c755a20344
- DOI
- 10.21203/rs.3.rs-4103623/v1
